The U.S. Food and Drug Administration has issued new warnings regarding the use of transvaginal surgical mesh to treat pelvic organ prolapse. The agency’s warnings are targeted at the placement of the mesh, citing that its use may actually carry greater risk than other surgical options, without any evidence of greater benefit. The number of [...]
